BR0008949A - Composições de lipoglicano e métodos de tratamento de infecções parasitárias - Google Patents

Composições de lipoglicano e métodos de tratamento de infecções parasitárias

Info

Publication number
BR0008949A
BR0008949A BR0008949-4A BR0008949A BR0008949A BR 0008949 A BR0008949 A BR 0008949A BR 0008949 A BR0008949 A BR 0008949A BR 0008949 A BR0008949 A BR 0008949A
Authority
BR
Brazil
Prior art keywords
lipoglycan
compositions
methods
parasitic infections
treating parasitic
Prior art date
Application number
BR0008949-4A
Other languages
English (en)
Inventor
Lloyd H Semprevivo
Original Assignee
Univ Massachusetts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Massachusetts filed Critical Univ Massachusetts
Publication of BR0008949A publication Critical patent/BR0008949A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

"COMPOSIçõES DE LIPOGLICANO E MéTODOS DE TRATAMENTO DE INFECçõES PARASITáRIAS". Composição e método de elicitar em um vertebrado uma resposta imune protetora contra parasita eucariótico são descritos. O método inclui administrar a um vertebrado uma composição tendo um grupo veículo ligado a um oligossacarídeo obtido a partir de lipoglicano descoberto sobre a superfície de um eucariota. A composição é administrada em uma quantidade suficiente para elicitar uma resposta imune protetora contra um parasita.
BR0008949-4A 1999-03-12 2000-03-10 Composições de lipoglicano e métodos de tratamento de infecções parasitárias BR0008949A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12393199P 1999-03-12 1999-03-12
PCT/US2000/006404 WO2000053220A1 (en) 1999-03-12 2000-03-10 Lipoglycan compositions and methods of treating parasitic infections

Publications (1)

Publication Number Publication Date
BR0008949A true BR0008949A (pt) 2002-09-24

Family

ID=22411778

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0008949-4A BR0008949A (pt) 1999-03-12 2000-03-10 Composições de lipoglicano e métodos de tratamento de infecções parasitárias

Country Status (17)

Country Link
US (3) US6428793B1 (pt)
EP (1) EP1175226B1 (pt)
JP (1) JP2002538220A (pt)
AT (1) ATE439857T1 (pt)
AU (1) AU771373B2 (pt)
BR (1) BR0008949A (pt)
CA (1) CA2364507A1 (pt)
DE (1) DE60042776D1 (pt)
HU (1) HUP0200466A3 (pt)
MA (1) MA25347A1 (pt)
MX (1) MXPA01009206A (pt)
NO (1) NO20014411L (pt)
NZ (1) NZ514112A (pt)
PL (1) PL203789B1 (pt)
TR (3) TR200103231T2 (pt)
WO (1) WO2000053220A1 (pt)
ZA (1) ZA200107502B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6756361B1 (en) * 1997-10-14 2004-06-29 Nabi Enterococcus antigens and vaccines
US7164520B2 (en) 2004-05-12 2007-01-16 Idc, Llc Packaging for an interferometric modulator
WO2006041613A2 (en) * 2004-10-05 2006-04-20 Nanomega Medical Corporation Nanoparticles for targeting hepatoma cells
EP2494980A3 (en) * 2009-10-21 2013-03-13 ETH Zurich Medical utility of glycans

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2598147B1 (fr) * 1986-04-30 1988-08-26 Pasteur Institut Immunogene isole de mollusques, son procede de preparation, reactifs de diagnostic des bilharzioses humaines, vaccins contre les schistosomiases et compositions immunisantes comprenant ledit immunogene.
FR2601021B2 (fr) * 1986-07-07 1988-11-18 Pasteur Institut Fraction immunogene active a l'egard des bilharzioses, sa preparation, compositions immunisantes la contenant
US5280113A (en) * 1989-08-16 1994-01-18 Monsanto Company Method for producing synthetic N-linked glycoconjugates
US5212298A (en) 1989-08-16 1993-05-18 Monsanto Company Method for producing synthetic N-linked glycoconjugates
US5679347A (en) * 1992-12-10 1997-10-21 Brigham And Women's Hospital Methods of isolating CD1-presented antigens, vaccines comprising CD1-presented antigens, and cell lines for use in said methods
US5541075A (en) * 1993-02-05 1996-07-30 Heska Corporation Carbohydrate-based vaccine and diagnostic reagent for trichinosis
BR9305075A (pt) * 1993-12-16 1995-08-08 Fundacao Oswaldo Cruz Antígeno para conferir imunidade protetora contra infecções helmínticas em humanos e animais,e processo de vacinação para aplicação na imunoprofilaxia de doenças helmintológicas de interesse veterinário e médico
US6261788B1 (en) * 1998-09-21 2001-07-17 The Board Of Regents Of The University Of Oklahoma Diagnostic assays for infectious parasitic helminths

Also Published As

Publication number Publication date
HUP0200466A2 (en) 2002-06-29
HUP0200466A3 (en) 2006-11-28
US7063848B2 (en) 2006-06-20
US20060228382A1 (en) 2006-10-12
TR200202066T2 (tr) 2004-12-21
TR200202078T2 (tr) 2002-11-21
US7204983B2 (en) 2007-04-17
WO2000053220A1 (en) 2000-09-14
TR200103231T2 (tr) 2002-03-21
MA25347A1 (fr) 2001-12-31
AU3625100A (en) 2000-09-28
ZA200107502B (en) 2003-02-26
NO20014411D0 (no) 2001-09-11
EP1175226A1 (en) 2002-01-30
NZ514112A (en) 2003-08-29
PL350989A1 (en) 2003-02-24
NO20014411L (no) 2001-11-09
CA2364507A1 (en) 2000-09-14
US20020160021A1 (en) 2002-10-31
JP2002538220A (ja) 2002-11-12
EP1175226A4 (en) 2005-01-05
ATE439857T1 (de) 2009-09-15
US6428793B1 (en) 2002-08-06
MXPA01009206A (es) 2003-07-14
DE60042776D1 (de) 2009-10-01
AU771373B2 (en) 2004-03-18
PL203789B1 (pl) 2009-11-30
EP1175226B1 (en) 2009-08-19

Similar Documents

Publication Publication Date Title
CO5560558A2 (es) Uso de una composicion de celecoxib para rapido alivio del dolor
FI970298A0 (fi) DHA:n käyttö farmaseuttisena koostumuksena
MY135988A (en) Additive for improving the water resistance of cosmetic or dermatological formulations
DK0778775T3 (da) Parenteral tirilazad-præparat med coopløsningsmiddel
MD1586G2 (ro) Inducere a unui răspuns citotoxic T-limfocitar
BRPI9810519B8 (pt) derivados de 4''-substituído-9-desoxo-9a-aza-9a-homoeritromicina a e composição farmacêutica compreendendo os mesmos.
AU2147992A (en) Immunogen compounds having specifically an anti-cytokine effect, method of preparation, pharmaceutical compositions and kits containing them
DE69304521T2 (de) Impfstoff Adjuvans
SE9704870D0 (sv) New pharmaceutical formulation I
PT692028E (pt) Farmacos baseados em papilomavirus
CA2378613A1 (en) Selective iglur5 receptor antagonists for the treatment of migraine
UA35611C2 (uk) Композиція місцевого застосування для інгібування росту волос у ссавців, спосіб із її використанням та композиція місцевого застосування для доставки водорозчинного фармакологічного засобу до шкіри
HK1038310A1 (en) Compositions and methods for treating intracellular infections.
NO972623L (no) Farmasöytisk blanding omfattende lamotrigin
BR9806971A (pt) Epìtopes de célula t universal para vacinas anti-malária.
DK1272177T3 (da) Fremgangsmåde og formulering til behandling af resistens over for antihypertensiva og forbundne tilstande
TNSN00145A1 (fr) Derives de streptogramines, leur preparation et les compositions qui les contiennent
BR0008949A (pt) Composições de lipoglicano e métodos de tratamento de infecções parasitárias
BR9815404A (pt) Composição adjuvante para estimular uma eficiente resposta imunológica a uma substância antigênica, vacina para administração a um animal, processo para estimular uma resposta imunológica eficaz em um animal a uma substância antigênica, e, uso da composição adjuvante.
AU1815899A (en) Method and composition to enhance the efficacy of a vaccine using chemokines
HK1138516A1 (en) Parenteral vaccine formulations and uses thereof
BR0312640A (pt) Formulação contra mycoplasma gallisepticum
MX9207150A (es) Metodo y composiciones para reducir la resistenciaa multiples farmacos.
MX227296B (en) Transparent skin care compositions
DK1007034T3 (da) Præparater indeholdende Bergamottin til forøgelse af den orale biotilgængelighed af farmaceutiske midler

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 12A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2142 DE 24/01/2012.